Sirio Pharma Co Ltd
SZSE:300791
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sirio Pharma Co Ltd
Cash from Operating Activities
Sirio Pharma Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sirio Pharma Co Ltd
SZSE:300791
|
Cash from Operating Activities
¥695.5m
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Cash from Operating Activities
¥3.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Cash from Operating Activities
¥1.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Cash from Operating Activities
¥694.9m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Cash from Operating Activities
¥1.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
7%
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Cash from Operating Activities
¥2B
|
CAGR 3-Years
30%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Sirio Pharma Co Ltd
Glance View
Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.
See Also
What is Sirio Pharma Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
695.5m
CNY
Based on the financial report for Sep 30, 2025, Sirio Pharma Co Ltd's Cash from Operating Activities amounts to 695.5m CNY.
What is Sirio Pharma Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
21%
Over the last year, the Cash from Operating Activities growth was 85%. The average annual Cash from Operating Activities growth rates for Sirio Pharma Co Ltd have been 21% over the past three years , 21% over the past five years .
